> Thus, optimally elicited human polyclonal antibodies against SARS-CoV-2 should be resilient to substantial future SARS-CoV-2 variation and may confer protection against potential future sarbecovirus pandemics.
So if I'm extrapolating correctly: any vaccine which can stimulate production of this or similar polyclonal antibodies should prove exceptionally difficult for the virus to overcome through evolutionary pressure.
Anyone more intelligent than me on this topic able to help me understand how likely this is to come to fruition?
So if I'm extrapolating correctly: any vaccine which can stimulate production of this or similar polyclonal antibodies should prove exceptionally difficult for the virus to overcome through evolutionary pressure.
Anyone more intelligent than me on this topic able to help me understand how likely this is to come to fruition?